Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative lignocaine for colorectal cancer surgery
ACTRN12618000754246Phase 3Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in colorectal cancer (CRC) comparing Lignocaine with Placebo (2 arms). Primary endpoint: Composite primary endpoint: change in natural killer cell function. Started Sep 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ACTRN12618000754246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000754246.